These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 19466513)

  • 21. Pharmacotherapy of triple-negative breast cancer.
    Arslan C; Dizdar O; Altundag K
    Expert Opin Pharmacother; 2009 Sep; 10(13):2081-93. PubMed ID: 19640211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency of the basal-like phenotype in African breast cancer.
    Nalwoga H; Arnes JB; Wabinga H; Akslen LA
    APMIS; 2007 Dec; 115(12):1391-9. PubMed ID: 18184410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triple-negative breast carcinoma in women from Vietnam and the United States: characterization of differential marker expression by tissue microarray.
    Williams DJ; Cohen C; To TV; Page AJ; Lawson D; Sussman ZM; Nassar A
    Hum Pathol; 2009 Aug; 40(8):1176-81. PubMed ID: 19368951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of luminal and basal cytokeratins in human breast carcinoma.
    Abd El-Rehim DM; Pinder SE; Paish CE; Bell J; Blamey RW; Robertson JF; Nicholson RI; Ellis IO
    J Pathol; 2004 Jun; 203(2):661-71. PubMed ID: 15141381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.
    Nielsen TO; Hsu FD; Jensen K; Cheang M; Karaca G; Hu Z; Hernandez-Boussard T; Livasy C; Cowan D; Dressler L; Akslen LA; Ragaz J; Gown AM; Gilks CB; van de Rijn M; Perou CM
    Clin Cancer Res; 2004 Aug; 10(16):5367-74. PubMed ID: 15328174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metaplastic breast carcinomas and their relationship with basal-like phenotype.
    Cakir A; Gönül II; Uluoğlu O
    Turk Patoloji Derg; 2012; 28(2):134-41. PubMed ID: 22627631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular classification of breast carcinomas by immunohistochemical analysis: are we ready?
    Tang P; Skinner KA; Hicks DG
    Diagn Mol Pathol; 2009 Sep; 18(3):125-32. PubMed ID: 19704256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis.
    Weigelt B; Kreike B; Reis-Filho JS
    Breast Cancer Res Treat; 2009 Sep; 117(2):273-80. PubMed ID: 18815879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presenting features of breast cancer differ by molecular subtype.
    Wiechmann L; Sampson M; Stempel M; Jacks LM; Patil SM; King T; Morrow M
    Ann Surg Oncol; 2009 Oct; 16(10):2705-10. PubMed ID: 19593632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triple-negative/basal-like breast cancer: clinical, pathologic and molecular features.
    Venkitaraman R
    Expert Rev Anticancer Ther; 2010 Feb; 10(2):199-207. PubMed ID: 20131996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of P-cadherin expression to basal phenotype of breast carcinoma.
    Potemski P; Kusińska R; Kubiak R; Piekarski JH; Płuciennik E; Bednarek AK; Kordek R
    Pol J Pathol; 2007; 58(3):183-8. PubMed ID: 18074863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.
    Livasy CA; Karaca G; Nanda R; Tretiakova MS; Olopade OI; Moore DT; Perou CM
    Mod Pathol; 2006 Feb; 19(2):264-71. PubMed ID: 16341146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity.
    Vincent-Salomon A; Gruel N; Lucchesi C; MacGrogan G; Dendale R; Sigal-Zafrani B; Longy M; Raynal V; Pierron G; de Mascarel I; Taris C; Stoppa-Lyonnet D; Pierga JY; Salmon R; Sastre-Garau X; Fourquet A; Delattre O; de Cremoux P; Aurias A
    Breast Cancer Res; 2007; 9(2):R24. PubMed ID: 17417968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling.
    López-Bonet E; Alonso-Ruano M; Barraza G; Vazquez-Martin A; Bernadó L; Menendez JA
    Oncol Rep; 2008 Dec; 20(6):1369-74. PubMed ID: 19020716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes.
    Melchor L; Honrado E; García MJ; Alvarez S; Palacios J; Osorio A; Nathanson KL; Benítez J
    Oncogene; 2008 May; 27(22):3165-75. PubMed ID: 18071313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AlphaB-crystallin: a novel marker of invasive basal-like and metaplastic breast carcinomas.
    Sitterding SM; Wiseman WR; Schiller CL; Luan C; Chen F; Moyano JV; Watkin WG; Wiley EL; Cryns VL; Diaz LK
    Ann Diagn Pathol; 2008 Feb; 12(1):33-40. PubMed ID: 18164413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of molecular breast cancer subtypes in middle eastern-saudi arabian women: a pilot study.
    Al-Tamimi DM; Bernard PS; Shawarby MA; Al-Amri AM; Hadi MA
    Ultrastruct Pathol; 2009; 33(4):141-50. PubMed ID: 19728229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Basal-like subtype of breast cancer: a review of its unique characteristics and their clinical significance.
    Kobayashi S
    Breast Cancer; 2008; 15(2):153-8. PubMed ID: 18311481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunohistochemically "ER-negative, PR-negative, HER2-negative, CK5/6-negative, and HER1-negative" subgroup is not a surrogate for the normal-like subtype in breast cancer.
    Yu KD; Shen ZZ; Shao ZM
    Breast Cancer Res Treat; 2009 Dec; 118(3):661-3. PubMed ID: 19714461
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling.
    Van Laere SJ; Van den Eynden GG; Van der Auwera I; Vandenberghe M; van Dam P; Van Marck EA; van Golen KL; Vermeulen PB; Dirix LY
    Breast Cancer Res Treat; 2006 Feb; 95(3):243-55. PubMed ID: 16261404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.